Proteomics International Laboratories Future Growth
Future criteria checks 2/6
Proteomics International Laboratories is forecast to grow earnings and revenue by 28.8% and 40.2% per annum respectively while EPS is expected to grow by 36.6% per annum.
Key information
28.8%
Earnings growth rate
36.6%
EPS growth rate
| Life Sciences earnings growth | 21.0% |
| Revenue growth rate | 40.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2027 | 10 | -2 | -2 | -1 | 1 |
| 6/30/2026 | 6 | -5 | -5 | -5 | 1 |
| 6/30/2025 | 3 | -8 | -7 | -6 | 1 |
| 6/30/2024 | 3 | -6 | -6 | -6 | N/A |
| 3/31/2024 | 3 | -6 | -6 | -5 | N/A |
| 12/31/2023 | 3 | -6 | -6 | -5 | N/A |
| 9/30/2023 | 3 | -6 | -6 | -5 | N/A |
| 6/30/2023 | 3 | -6 | -7 | -6 | N/A |
| 3/31/2023 | 3 | -6 | -6 | -5 | N/A |
| 12/31/2022 | 4 | -6 | -5 | -4 | N/A |
| 9/30/2022 | 3 | -5 | -4 | -4 | N/A |
| 6/30/2022 | 3 | -5 | -4 | -4 | N/A |
| 3/31/2022 | 3 | -5 | -3 | -3 | N/A |
| 12/31/2021 | 3 | -4 | -3 | -3 | N/A |
| 9/30/2021 | 3 | -4 | -3 | -3 | N/A |
| 6/30/2021 | 3 | -3 | -2 | -2 | N/A |
| 3/31/2021 | 3 | -3 | -1 | -1 | N/A |
| 12/31/2020 | 2 | -2 | 0 | 0 | N/A |
| 9/30/2020 | 3 | -2 | -1 | 0 | N/A |
| 6/30/2020 | 3 | -2 | -2 | 0 | N/A |
| 3/31/2020 | 3 | -2 | -3 | -1 | N/A |
| 12/31/2019 | 3 | -2 | -3 | -2 | N/A |
| 9/30/2019 | 3 | -2 | -2 | -2 | N/A |
| 6/30/2019 | 3 | -2 | -2 | -2 | N/A |
| 3/31/2019 | 3 | -2 | -2 | -2 | N/A |
| 12/31/2018 | 3 | -2 | -1 | -1 | N/A |
| 9/30/2018 | 2 | -2 | -1 | -1 | N/A |
| 6/30/2018 | 2 | -1 | -1 | -1 | N/A |
| 3/31/2018 | 2 | -1 | N/A | -1 | N/A |
| 12/31/2017 | 2 | -1 | N/A | -1 | N/A |
| 9/30/2017 | 2 | -1 | N/A | -1 | N/A |
| 6/30/2017 | 2 | -1 | N/A | -1 | N/A |
| 3/31/2017 | 2 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 2 | -1 | N/A | -1 | N/A |
| 9/30/2016 | 2 | -1 | N/A | -1 | N/A |
| 6/30/2016 | 1 | -1 | N/A | -2 | N/A |
| 3/31/2016 | 1 | -2 | N/A | -1 | N/A |
| 12/31/2015 | 1 | -2 | N/A | -1 | N/A |
| 9/30/2015 | 1 | -2 | N/A | -1 | N/A |
| 6/30/2015 | 1 | -1 | N/A | -1 | N/A |
| 6/30/2014 | 1 | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PIQ is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PIQ is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PIQ is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PIQ's revenue (40.2% per year) is forecast to grow faster than the Australian market (5.6% per year).
High Growth Revenue: PIQ's revenue (40.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PIQ's Return on Equity is forecast to be high in 3 years time